ARTICLE | Clinical News
Mirvaso brimonidine tartrate regulatory update
March 3, 2014 8:00 AM UTC
The European Commission approved an MAA from Galderma for Mirvaso brimonidine tartrate for the symptomatic treatment of facial erythema of rosacea in adult patients. Galderma launched the product in t...